✦ LIBER ✦

Small molecule modulators of cyclin-dependent kinases for cancer therapy

✍ Scribed by Senderowicz, Adrian M

Book ID: 110064390
Publisher: Nature Publishing Group
Year: 2000
Tongue: English
Weight: 155 KB
Volume: 19
Category: Article
ISSN: 0950-9232
DOI: 10.1038/sj.onc.1204085

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Small-molecule cyclin-dependent kinase m

Small-molecule cyclin-dependent kinase modulators

✍ Senderowicz, Adrian M 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 203 KB

Cyclin dependent kinases as targets for

Cyclin dependent kinases as targets for cancer therapy

✍ Manish A. Shah; Gary K. Schwartz 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 534 KB

Small Molecules as Inhibitors of Cyclin-

Small Molecules as Inhibitors of Cyclin-Dependent Kinases

✍ Axel Huwe; Ralph Mazitschek; Athanassios Giannis 📂 Article 📅 2003 🏛 John Wiley and Sons ⚖ 51 KB 👁 2 views

Small Molecules as Inhibitors of Cyclin-

Small Molecules as Inhibitors of Cyclin-Dependent Kinases

✍ Axel Huwe; Ralph Mazitschek; Athanassios Giannis 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 428 KB 👁 2 views

Development of anaplastic lymphoma kinas

Development of anaplastic lymphoma kinase (ALK) small-molecule inhibitors for cancer therapy

✍ Rongshi Li; Stephan W. Morris 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 433 KB

## Abstract Anaplastic lymphoma kinase (ALK) is a receptor tyrosine kinase (RTK) involved in the genesis of several human cancers; indeed, ALK was initially identified in constitutively activated and oncogenic fusion forms—the most common being nucleophosmin (NPM)‐ALK—in a non‐Hodgkin's lymphoma (N

Review of flavopiridol, a cyclin-depende

Review of flavopiridol, a cyclin-dependent kinase inhibitor, as breast cancer therapy

✍ Antoinette R. Tan; Sandra M. Swain 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 102 KB